Friday, June 30, 2017

Spirent Supports New H3C in Industry’s Highest Density 100 Gigabit Ethernet Data Center Switch Performance Test

Record-breaking test comprised 768 ports of 100GbE with throughput of more than 100 million frames per second

BEIJING -Friday, June 30th 2017 [ ME NewsWire ]
(BUSINESS WIRE)-- Spirent Communications, Plc (LSE: SPT), the industry leader in Ethernet test and measurement, announced today the successful support of New H3C in the industry’s highest density 100G data center switch test ever conducted. The test, completed by Spirent Communications and the New H3C Group and moderated by independent test lab Network Test, tested the line-rate forwarding capacity and hyper-scale IP route announcement capacity of the H3C S12500X-AF chassis full of 100G ports with a density of 768 100G ports per chassis.
According to David Newman of Network Test, “With 768 ports, this is the largest 100G Ethernet switch test successfully completed in the industry so far. The stress tests we conducted involved nearly 1 million unique BGP routes as well as 768 concurrent EVPN instances within a single chassis. These benchmarks, based on open testing standards, successfully verified New H3C data center core switches, with Spirent TestCenter providing the high density, high performance, and high flexibility required for this record-breaking project.”
The test was conducted using Spirent TestCenter® and the Spirent N11U chassis, Spirent’s flagship network performance test solution. The Spirent N11U chassis included the high density dX3 12-port 100G test modules capable of verifying next-generation data center architectures and routers. Spirent TestCenter generated 100G line-rate transaction traffic of various frame lengths, and provided packet loss, latency, jitter, frame sequence, code errors and FCS error analytics to reflect the quality of transmission in real time.
“The S12500X-AF series of switches provide a maximum of 48 100G QSFP28 pluggable optical modules per slot, which is the highest density in the world, with New H3C being the only vendor in the industry to provide full line-rate 768 100G ports for datacenter core switches,” said Steven Yoe, Senior Vice President and CTO of the New H3C Group. “We were pleased to work with Spirent to verify the performance of S12500X-AF and achieve satisfactory test results.”
“Generation after generation of Spirent Ethernet testing technologies have helped our customers take advantage of market opportunities. We appreciate New H3C Group for selecting Spirent as a trusted testing partner for verifying the performance of its S12500X-AF series of switches” said Eric Hutchinson, CEO of Spirent Communications.
The Spirent dX3 quint-speed test module supports twelve 100G or 40G ports per slot, or twenty five 50G ports, or forty eight 25G or 10G ports per slot. It also supports key interface features such as FEC, Auto-negotiation and Link Training. It can be used to verify data plane Quality of Service (QoS) for hyper-dense network devices at line-rate, and to test complex routing, data center and access protocols on switches and routers.
Click here to download the test report.
For more information on Spirent TestCenter and the dX3 module, please visit http://www.spirent.comn/Products/TestCenter.
About Spirent Communications plc
Spirent Communications plc. (LSE: SPT) is the leading provider of verification, assessment, analytics, and device intelligence solutions. We enable those who deliver networks, connected devices, and communication services to provide a superior user experience. From service provider networks and enterprise datacenters to mobile communications and connected vehicles, Spirent works with leading innovators to help the world communicate and collaborate faster, better, and more securely. For more information visit: http://www.spirent.com/About-Us/News_Room.
About H3C
New H3C Group (New H3C) is a world-leading provider of New IT solutions. It is fully committed to the research & development, production, sales, consulting and services of New IT products and solutions. Providing customers with a full range of servers, storage, networking, security products, hyper-converged infrastructure and IT management systems under the H3C® brand, New H3C also offer customers a one-stop, complete portfolio of IT solutions and consulting services that includes Big Internet, Big Security, Cloud Computing and Big Data. In addition, New H3C is also the exclusive provider of HPE® branded Servers and Storage products as well as Technical Services in China.
Contacts
Americas
SSPR
John Nelson, +1 312-750-9081
spirent@sspr.com
or
Asia Pacific
Spirent Communications
Janet Peng, +86 (10) 82330055 x160
janet.peng@spirent.com
or
Europe
Spirent Communications
Simon Loe, +44 (0) 7850 205885
simon.loe@spirent.com

Permalink : http://me-newswire.net/news/4175/en

Asus Selects OT-Morpho’s eSIM for the First Microsoft Windows 10 Tablet Computer Compliant with GSMA Specifications

PARIS -Friday, June 30th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- OT-Morpho, a world leader in digital security and identification technologies, today announced that ASUS has selected its embedded SIM (eSIM) to enable cellular connectivity for the new ASUS Transformer Mini, a hybrid tablet computer running with Windows 10 that will be launched this summer. The ASUS Transformer Mini will be the first computer device available on the market with an eSIM solution compatible with GSMA Phase 2 specifications for consumer devices.

DakOTa 4.0 eSIM contributes to enhance the Always Connected Windows user experience. It has been designed in compliance with the GSMA specifications to ensure the best compatibility with MNO networks worldwide and thus allow the largest coverage capabilities. It fully addresses the specific subscription management needs for consumer devices. Validated for Microsoft Windows 10, it enables device makers such as ASUS to offer greater connectivity capabilities for laptops, notebooks and other personal computer devices using Windows OS.

To stay connected anywhere, users will no longer need to buy various SIM cards when travelling. The eSIM will enable ASUS Transformer Mini owners to download the subscription they need by selecting one of the available cellular networks directly from their device. Furthermore, thanks to the initial cellular connectivity embedded in their device, they will be able to connect to the Microsoft Data Market place to select the subscription of their choice wherever they are, even if they do not have access to WiFi.

“We position ourselves as a champion of connectivity in the personal computer space and we are excited to provide our customers with access to cellular connectivity anytime, anywhere,” said S.Y. Shian, COO & Head of PC Business Unit at ASUS.

“We are very pleased to take part to the first GSMA Phase 2 eSIM deployment in personal computers with ASUS. Our close collaboration with Microsoft, notably with the two test labs we recently opened in the US and in Asia, allows us to offer the best-in-class support to our OEM customers for the integration of the eSIM technology to tablets, laptops and notebooks,” added Yves Portalier, OT-Morpho, Vice President & General Manager, Telecom, Morpho.

“Together with OT-Morpho, we anticipate the tremendous potential that eSIM technology has to transform connectivity usage in the personal computer space and we are working hand-in-hand to facilitate its deployment with the Windows 10 platform. We are very pleased to support ASUS in delivering extended cellular connectivity capabilities to their customers,” said Roanne Sones, General Manager, Strategy and Ecosystem for Windows and Devices at Microsoft.

Visitors to the MWC Shanghai (28-30 June 2017) will have the opportunity to discover the eSIM subscription management solution (stand W4.G01).

------

OT-Morpho is a world leader in digital security & identification technologies with the ambition to empower citizens and consumers alike to interact, pay, connect, commute, travel and even vote in ways that are now possible in a connected world.

As our physical and digital, civil and commercial lifestyles converge, OT-Morpho stands precisely at that crossroads to leverage the best in security and identity technologies and offer customized solutions to a wide range of international clients from key industries, including Financial services, Telecom, Identity, Security and IoT.

With close to €3bn in revenues and more than 14,000 employees, OT-Morpho is the result of the merger between OT (Oberthur Technologies) and Safran Identity & Security (Morpho) completed on 31 May 2017. Temporarily designated by the name

"OT-Morpho", the new company will unveil its new name in September of this year.

Contacts

OT-Morpho
Julien TAHMISSIAN, +33(0)158479054
julien.tahmissian@havas.com

GSMA Announces Additional Speakers for Mobile 360 Series – Africa

 Mobile for Development Utilities Innovation Fund Launches New Call for Applications



LONDON -Thursday, June 29th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- The GSMA today announced additional speakers participating in the 2017 Mobile 360 – Africa conference, which will take place 11 – 13 July 2017 at the Julius Nyerere International Convention Centre, Dar es Salaam, Tanzania. Additionally, the GSMA announced that its Mobile for Development Utilities programme has launched a new call for applications for its Innovation Fund. Further, Vodacom has also been confirmed as Host Sponsor for Mobile 360-Africa.

“Mobile 360 – Africa is now only two weeks away and we are looking forward to convening players from across the mobile ecosystem and adjacent industries to discuss the unprecedented opportunity that mobile provides to improve and enhance social and economic development in the region,” said Michael O’Hara, Chief Marketing Officer, GSMA.

At Mobile 360 – Africa, CEOs and senior executives from leading mobile companies and from players across the digital ecosystem will address the most pressing mobile trends and issues. New speakers confirmed to join the existing line-up at Mobile 360 – Africa include:

    Marisa Conway, Chief Learning Officer, Arifu
    Kees Van Lede, CEO, Carepay Ltd
    Eric Osiakwan, Managing Partner, Chanzo Capital
    Wale Ayeni, Regional head, Venture Capital – Africa, International Finance Corporation
    Lilian Makoi, Founder and CEO, Jamii Africa
    Catherine McCarthy, Chief Executive Officer, Medical Aid Films
    Mohamed, Dabbour, Executive Vice President, Africa, Millicom
    Dorcas Muthoni, CEO and Founder, Openworld
    Thomas Chalumeau, Chief Strategy Officer, Orange MEA
    Bob Collymore, CEO, Safaricom
    Peter Kariuki, Co-Founder and CTO, Safemotos
    Evan Thomas, CEO, SweetSense

Over the three days, the conference will feature thought-provoking keynote addresses, fireside chats, and panel discussions. Day One looks at the role of government and industry in delivering social and digital transformation; Day Two highlights and celebrates the companies and projects leading the digitisation of Africa; and finally, Day Three takes an in-depth look into mobile money and financial inclusion.

The conference will also examine different aspects of the empowerment story, with sessions including: ‘What Does a Digital Future Look Like for Africa?’, ‘Mobile as a Platform for Achieving SDGs in Africa’, ‘Expanding and Enhancing Mobile Broadband Connectivity’, and ‘Pathways to Social Transformation: Identity and Inclusion’.

For the first time, the programme will feature a ‘Predictions Panel’, where thought leaders from throughout the industry will gather to share and debate their predicted outcomes of Digital Africa in the next 12 months. Confirmed to join so far are:

    Dorcas Muthoni, CEO and Founder, Openworld
    Mariam Abdullahi, Africa Industry Lead, Telecommunications, SAP Africa
    Simon Karikari, CEO, Tigo Tanzania

In addition to the main conference, Mobile 360 – Africa will highlight the initiatives and activities undertaken by the GSMA Mobile for Development programme. These include the programme’s work to: increase access to and use of life-enhancing mobile services; accelerate socio-economic improvements for the underserved, particularly women, rural populations and youth; drive digital and financial inclusion; and promote the adoption of identity for the unregistered.

Call for Applications to Utilities Innovation Fund

Supported by the UK Government, the M4D Utilities Innovation Fund aims to test and scale the use of mobile to improve or increase access to energy, water and sanitation services. Through the first two phases of funding, grants have been competitively awarded to 34 organisations across four continents, amounting to GBP 5.6 million and creating a direct impact to over 2.5 million people. For further information on how to apply for funding, please visit www.gsma.com/mobilefordevelopment/programmes/m4dutilities/innovation-fund-2.

Increased Networking Opportunities

All attendees are invited to join Millicom and GSMA Mobile for Development for the Mobile 360 – Africa Networking Drinks Reception sponsored by Millicom on Wednesday 12 July, 17:30-19:30. The GSMA’s Connected Society and Connected Women programmes will be co-hosting the reception under the theme of ‘Connecting the Unconnected: Accelerating Inclusion’. The reception will serve to congratulate the Connected Women Commitment partners on their efforts to close the digital divide in Africa, and will recognise and celebrate the collaboration between Airtel, Tigo and Vodacom with vendors Ericsson, Huawei and Nokia Systems, as well as UCSAF and the Tanzanian government in helping to connect 70,000 people in rural Tanzania as part of the Connected Society programme.

Get Involved at Mobile 360 – Africa

The 2017 GSMA Mobile 360 Series – Africa is the third in a series of eight industry-focused events held in major cities across the world. For information on Mobile 360 – Africa, please visit www.mobile360series.com/africa. Follow developments and updates on Mobile 360 – Africa (#m360Africa) on Twitter @GSMA, on Facebook www.facebook.com/Mobile360Series and LinkedIn on www.linkedin.com/company/gsma-mobile-360-series.

About the GSMA

The GSMA represents the interests of mobile operators worldwide, uniting nearly 800 operators with more than 300 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces industry-leading events such as Mobile World Congress, Mobile World Congress Shanghai, Mobile World Congress Americas and the Mobile 360 Series of conferences.

For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.

Contacts

Media:
For the GSMA
Charlie Meredith-Hardy
+44 7917 298428
CMeredith-Hardy@webershandwick.com
or
David Ntwampe Maila
+ 27 72 015 4702
dmaila@webershandwick.com
or
GSMA Press Office
pressoffice@gsma.com

Permalink : http://www.me-newswire.net/news/4172/en 

Machine Learning Comes to Tour De France

Deeper race insights on the cards for cycling fans around the world

LONDON & PARIS-Thursday, June 29th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- Amaury Sport Organisation (A.S.O.), organisers of the Tour de France, and Dimension Data, the Official Technology Partner of the Tour de France, today announced the introduction of machine learning technologies at this year’s Tour de France to give cycling fans across the globe an unprecedented experience of this year’s event. The race begins in Düsseldorf on Saturday and finishes at the Champs-Élysées in Paris on 23 July.

This year, Dimension Data’s data analytics platform, which was developed in partnership with A.S.O., incorporates machine learning and complex algorithms that combine live and historical race data to provide even deeper levels of insight as the race unfolds. Fans will also benefit from rider profiles to understand more about environments and circumstances in which riders perform best.

As part of a new pilot this year, A.S.O. and Dimension Data are exploring the role of predictive analytics technologies to assess the likelihood of various race scenarios, such as whether the peloton will catch the breakaway riders at certain stages of the race.

Scott Gibson, Dimension Data’s Group Executive – Digital Practice said, “As more technology is introduced into sport, the viewing experience is transforming, and its popularity increases. What’s especially exciting for us is how we’re helping A.S.O. to attract a new generation of digitally savvy fans, and how advanced technologies like machine learning are opening up new possibilities for providing the insights that today’s fans demand.”

At the core of the live tracking and data analytics solution are GPS transponders installed under the saddles of each bike. The data collected from these transponders is combined with external data about the course gradient and prevailing weather conditions to generate insights such as live speed and the location of individual riders, distance between riders, and composition of groups within the race. This year, the solution will create and analyse over 3 billion data points during the 21 stages of the Tour, a significant increase from last year’s 128 million data points.

Christian Prudhomme, Director of the Tour de France, A.S.O. said, “Today, our followers want to be immersed in the event. They’re more digitally engaged on social media than ever before, and want a live and compelling second-screen experience during the Tour. Technology enables us to completely transform their experience of the race.”

The enhanced Tour de France solution uses a fully cloud-based, virtualised data centre which provides scale, and means fewer people are required on the ground to enable the solution. The cloud also provides geographic flexibility because it can be managed from anywhere in the world. This year, Dimension Data’s technical teams work together across four continents via hyperconnected mobile collaboration hubs equipped with the latest digital and virtual workplace technologies.

Some Tour de France highlights include:

    198 riders in 22 teams will generate over 150 million geospatial and environmental data readings along the 3,540km route.
    The Tour de France live-tracking website, racecenter.letour.fr, which supported an average of 2,000 page requests per second in 2016, has been enhanced to support 25,000 page requests per second this year.
    In 2016 there were 6,100 hours of TV broadcasts in 190 countries across 100 channels globally. Thanks to A.S.O., the number of TV broadcast hours will increase from 80 in 2016 to 105 this year and the race will be broadcast starting from the first kilometre of every stage.
    Cybersecurity is a top priority for the Tour de France. During the 2016 race, Dimension Data’s cloud-based security system flagged 1,409,769 suspicious access attempts which were blocked.

Visit Dimension Data’s Tour de France microsite
View video
Dimension Data’s Tour de France newsroom
Follow us on @letourdata for live race data updates on A.S.O’s official twitter channel
Follow the progress of the race with live tracking on racecenter.letour.fr

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170628006009/en/

Contacts

Dimension Data
Hilary King, tel: +2782 414 9623
Global PR Manager
email: hilary.king@dimensiondata.com
or
Marion GACHIES, tel: +33.6.07.02.42.17
A.S.O. press officer
email: mgachies@aso.fr


Permalink : http://me-newswire.net/news/4162/en

Thursday, June 29, 2017

TNT Express Operations Disrupted

 All Other FedEx Services Operating Normally



MEMPHIS, Tenn.-Thursday, June 29th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- FedEx Corporation (NYSE: FDX) today announced that the worldwide operations of its TNT Express subsidiary have been significantly affected due to the infiltration of an information system virus. While TNT Express operations and communications systems have been disrupted, no data breach is known to have occurred. The operations of all other FedEx companies are unaffected and services are being provided under normal terms and conditions.

Remediation steps and contingency plans are being implemented as quickly as possible. TNT Express domestic country and regional network services are largely operational, but slowed. We are also experiencing delays in TNT Express inter-continental services at this time. We are offering a full range of FedEx Express services as alternatives.

Updates on service availability will be provided periodically as systems are remediated. Customers seeking updated information on service availability should call TNT Express Customer Service or visit TNT Express’s website at tnt.com.

We cannot measure the financial impact of this service disruption at this time, but it could be material.

About FedEx

FedEx Corp. (NYSE: FDX) provides customers and businesses worldwide with a broad portfolio of transportation, e-commerce and business services. With annual revenues of $60 billion, the company offers integrated business applications through operating companies competing collectively and managed collaboratively, under the respected FedEx brand. Consistently ranked among the world's most admired and trusted employers, FedEx inspires its more than 400,000 team members to remain "absolutely, positively" focused on safety, the highest ethical and professional standards and the needs of their customers and communities. To learn more about how FedEx connects people and possibilities around the world, please visit about.fedex.com.

Contacts

FedEx
Media Relations:
Patrick Fitzgerald, 901-818-7300




Permalink : http://www.me-newswire.net/news/4169/en 

Cable’s First Live Pay-Per-View Sports Event in Ultra HD Delivered by iN DEMAND with SES Video

Cable industry’s live Ultra HD broadcast of Mixed Martial Arts (MMA) bouts, produced by Bellator NYC, marks milestone for MVPDs in the US

LUXEMBOURG -Thursday, June 29th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- SES (Euronext Paris:SESG) (LuxX:SESG) today announced the successful delivery of iN DEMAND and cable’s first 4K live Pay-Per-View (PPV) sports event broadcast, Bellator NYC: Sonnen vs Silva Mixed Martial Arts, over the SES Ultra HD distribution platform.

On June 24, bouts from the action-packed blockbuster event were transmitted live from New York’s Madison Square Garden to cable and IPTV subscribers in select markets on PPV, offering them a compelling 4K experience. The broadcast also marked a milestone in network trials for MVPDs (Multichannel Video Programming Distributors) nationwide.

“Live sports offer up some of the most immersive Ultra HD experiences on television today, and there’s no better way to deliver high quality, live 4K programming to subscriber homes than by satellite,” explained Steve Corda, Vice President of Business Development in North America for SES Video. “The long-term, collaborative relationship between SES and iN DEMAND continues to innovate and create new opportunities for MVPDs and their audiences throughout North America and beyond. We greatly appreciate iN DEMAND for entrusting SES and our Ultra HD platform to distribute this first-ever 4K live sporting event to Pay TV homes and systems in the US.”

“The SES Ultra HD platform has enabled iN DEMAND to take our immersive PPV sports offerings to a whole new level of stunning, realistic sports action television,” said John Schultz, Vice President of Broadcast Operations at iN DEMAND. “The Bellator-produced MMA event in 4K was a first step in bringing the latest generation of video to our affiliates.”

More than 25 MVPDs, with a combined audience of nearly 10 million subscribers, are testing SES’s all-in-one Ultra HD solution, which packages the world’s largest 4K Ultra HD channel line-up, satellite distribution services, and reception equipment. Programming on the SES Ultra HD line-up features ten 4K Ultra HD channels, including Fashion One 4K, Travelxp 4K, 4KUNIVERSE, NASA TV UHD, INSIGHT TV, UHD1, C4K360, Funbox UHD, Nature Relaxation 4K as well as SES’s UHD demonstration channel. These channels are hosted on a trio of SES satellites at the centre of the orbital arc (SES-1, SES-3, AMC-18), which cover 100% of the cable head-ends in the US.

Follow us on:

Twitter: https://twitter.com/SES_Satellites

LinkedIn: https://www.linkedin.com/company/ses

Facebook: https://www.facebook.com/SES.Satellites

YouTube: http://www.youtube.com/SESVideoChannel

Blog: https://www.ses.com/news/blogs

Media Gallery: https://www.ses.com/media-gallery

SES White papers are available under: https://www.ses.com/news/whitepapers

About SES

SES is the world-leading satellite operator and the first to deliver a differentiated and scalable GEO-MEO offering worldwide, with more than 50 satellites in Geostationary Earth Orbit (GEO) and 12 in Medium Earth Orbit (MEO). SES focuses on value-added, end-to-end solutions in two key business units; SES Video and SES Networks. The company provides satellite communications services to broadcasters, content and internet service providers, mobile and fixed network operators, governments and institutions. SES’s portfolio includes the ASTRA satellite system, which has the largest Direct-to-Home (DTH) television reach in Europe, O3b Networks, a global managed data communications service provider, and MX1, a leading media service provider that offers a full suite of innovative digital video and media services. Further information available at: www.ses.com



Contacts

For further information please contact:
Markus Payer
Corporate Communications
Tel. +352 710 725 500
Markus.Payer@ses.com



Permalink : http://me-newswire.net/news/4173/en

Ekimetrics Official Partner of Facebook Portal Dedicated to MMM (Marketing Mix Modeling)

The French global analytics consultancy was chosen as a trusted third-party dedicated to increasing the reliability of advertising performance metrics on Facebook networks

PARIS -Tuesday, June 27th 2017 [ ME NewsWire ]
(BUSINESS WIRE)-- Ekimetrics (www.ekimetrics.com), a leading practitioner in data analytics and marketing intelligence for over 10 years, has announced that they are joining the Marketing Mix Modeling Program.
The companies who are part of the Facebook MMM Partner Program focus on measuring advertising’s impact on Facebook, Instagram and Facebook Audience Network. Advertisers need to measure the outcomes of their media investments, and identify correlations between their brand and an impact on their sales.
Ekimetrics will enable advertisers to acquire a better understanding of their media mix in different channels. They will be able to compare the effectiveness of offline/online investments with the kind of accuracy that has been expected for a long time.
Measuring digital and social ROI: accuracy and granularity at a level never achieved before
Ekimetrics will offer a solution for measuring the unique market ROI, which will be able to quantitatively measure the impact of advertising investments on sales and on the brand, as well as compare investments between different social networks with a granularity by category, product, country and content that is well above current practices.
Ekimetrics is recognized for its strong industry knowledge and disruptive approaches. Facebook teams audited Ekimetrics’ methods in depth before choosing the company among the first partners. This French nugget has now become a key provider for Marketing, Insights and Media Managers internationally (Asian social platforms such as Baidu, Wechat... will also be included). Ekimetrics will also participate in developing new solutions to continuously enhance the world leader’s commitment to transparency.
Quentin Michard, CEO Ekimetrics UK/HK and Manager of the partnership with Facebook: The fact that Facebook has chosen us is a recognition of our unique expertise in marketing ROI thanks to innovative methodologies. This will be a great opportunity for our customers and partners to bring tangible enhancements to measuring digital and social ROI, breaking with traditional and still very incomplete allocation methods. This is also the result of 10 years of experience in data, and of our philosophy which, from the start, has always been to combine human and technological intelligence.
About Ekimetrics: www.ekimetrics.com
Founded in 2006, Ekimetrics is an global analytics consultancy, leading practitioner in data analytics and marketing intelligence. Ekimetrics optimizes business strategies through innovative statistical methods. A pioneer in data science and a leader in its market in France and in Europe. The company now has projects in over 40 countries with 5 offices in Paris, London, New York, Hong-Kong and Dubai.
The team of 150 consultants creates customized approaches that can answer the most complex business questions, in such varied industries as automotive, luxury, cosmetics, telecommunications, distribution...
Ekimetrics is unique in its approach combining human intelligence, data and technology. The diversity of profiles - both consultants and statisticians - results in deliverables that are very trade- or business- oriented, unique in the market, and with a focus on ROI.
Contacts
Ekimetrics
Press Contact
MEIJI COMMUNICATION
Sandra Laberenne, +33 6.43.19.13.88
slaberenne@Meiji-communication.com

Permalink : http://me-newswire.net/news/4149/en

MPEG LA Introduces License for EVS

EVS delivers unprecedented voice and music quality to mobile phones and other devices


DENVER -Wednesday, June 28th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- MPEG LA, LLC today announced the availability of the EVS Patent Portfolio License providing efficient access to technologies underlying the EVS (Enhanced Voice Services) standard.

Designed to operate ubiquitously over packet-switched mobile and fixed-line communications networks, EVS represents a significant advance for voice and audio compression devices with compression, network capacity and other features that deliver vastly improved high definition quality for both music and voice services. EVS may be used in products such as mobile and landline phones, videoconferencing systems, desktop computers, tablets and connected home voice response systems.

“In an era when smartphones can do virtually anything, voice quality has lagged, but now the much anticipated EVS standard transmits speech of such pure quality that consumers will experience a dramatic leap in sound clarity and efficiency over prior technologies,” said Larry Horn, President and CEO of MPEG LA. “MPEG LA is proud to offer a convenient one-stop license to assist with EVS’s rapid market adoption, and we applaud the developers of this groundbreaking technology for making it widely accessible on reasonable terms.”

Current patent owners include Fraunhofer-Gesellschaft zur Foerderung der angewandten Forschung e.V.; Nippon Telegraph and Telephone Corporation (NTT); NTT DOCOMO, INC.; Panasonic Corporation; and Telefonaktiebolaget LM Ericsson.

“The license is specially designed for rapid product deployment,” said Bill Geary, MPEG LA Vice President of Business Development. “To encourage early stage adoption, it provides for no royalty on the first 50,000 EVS products sold annually, waives the royalty for network devices during the initial term, and requires no up-front fees or annual minimums.”

Copies of the EVS license agreement may be obtained at http://www.mpegla.com/main/programs/EVS/Pages/AgreementExpress.aspx. A summary of the license terms may be found at http://www.mpegla.com/main/programs/EVS/Documents/EVSWeb.pdf.

MPEG LA’s objective is to provide worldwide access to as much EVS essential intellectual property as possible for the benefit of the market. Therefore, MPEG LA welcomes any party that believes it has patents that are essential to the EVS standard to submit them for an evaluation of their essentiality by MPEG LA’s patent experts and inclusion in the License if determined to be essential. Interested EVS patent owners may request a copy of the terms and procedures governing patent submissions at http://www.mpegla.com/main/programs/EVS/Pages/Licensors.aspx.

MPEG LA, LLC

MPEG LA is the world’s leading provider of one-stop licenses for standards and other technology platforms. Starting in the 1990s, it pioneered the modern-day patent pool helping to produce the most widely used standards in consumer electronics history. MPEG LA has operated licensing programs for a variety of technologies consisting of more than 14,000 patents in 84 countries with some 230 patent holders and more than 6,000 licensees. By assisting users with implementation of their technology choices, MPEG LA offers licensing solutions that provide access to fundamental intellectual property, freedom to operate, reduced litigation risk and predictability in the business planning process. In turn, this enables inventors, research institutions and other technology owners to monetize and speed market adoption of their assets to a worldwide market while substantially reducing the cost of licensing. MPEG LA is also developing patent pools for CRISPR gene editing and advanced battery technologies, and has conceived licensing ventures for molecular diagnostics and oligonucleotide therapeutics. For more information, go to www.mpegla.com.

Contacts

MPEG LA, LLC
Tom O’Reilly, 303-200-1710
Fax: 301-986-8575
toreilly@mpegla.com



SES and SaT5G to Spearhead Development of Ubiquitous 5G Network Capabilities

SaT5G consortium tasked to drive the integration of satellite into 5G networks

LUXEMBOURG-Thursday, June 29th 2017 [ ME NewsWire ]

BUSINESS WIRE)-- SES (Euronext Paris:SESG) (LuxX:SESG) announced today that the Satellite and Terrestrial Network for 5G (SaT5G) consortium, comprising SES and 15 further members, has been tasked to integrate satellite into 5G networks, enabling ubiquitous and instantaneous 5G coverage and capacity.

Funded by the European Commission under the 5G PPP Phase 2 of the Horizon 2020 programme for Research & Innovation, the 30-month project will kick off in June 2017. It aims to deliver the seamless integration of satellite into 5G networks to ensure ubiquitous 5G access everywhere. The consortium will be focusing on extending 5G security to satellite, exploiting multicast for content distribution and driving relevant standardisation efforts mainly in 3rd Generation Partnership Project (3GPP) and European Telecommunications Standards Institute (ETSI). The key enabling technologies will be trialled and assessed through live testbed demonstrations across Europe.

Karim Michel Sabbagh, President and CEO at SES, said, “Maximum service coverage and capacity are key 5G deployment objectives, and these can be attained more effectively and quickly by the joint efforts of terrestrial and satellite infrastructures working together. SES’s geostationary orbit and medium earth orbit high throughput satellites are well positioned to provide massive capacity. Being the first of its kind, the SaT5G consortium is pleased to be spearheading the trials which will demonstrate these capabilities, and to cement Europe’s global leadership in 5G.”

About the SaT5G consortium

The Satellite and Terrestrial Network for 5G (SaT5G) consortium consists of 16 partners: Avanti Communications, Thales Alenia Space France, University of Surrey, SES, Airbus Defence and Space, OneAccess, TNO (Nederlandse Organisatie Voor Toegepast Natuurwetenschappelijk Onderzoek), British Telecommunications, Zodiac Inflight Innovations, Broadpeak, Gilat Satellite Networks, VT iDirect, imec, i2CAT Foundation, University of Oulu and Quortus. The consortium's main goal is to research, develop and validate key technologies required to enable the plug-and-play integration of satellite communications into 5G networks. The SaT5G consortium’s project coordinator is Avanti Communications.

Follow us on:

Twitter: https://twitter.com/SES_Satellites

LinkedIn: https://www.linkedin.com/company/ses

Facebook: https://www.facebook.com/SES.Satellites

YouTube: http://www.youtube.com/SESVideoChannel

Blog: https://www.ses.com/news/blogs

Media Gallery: https://www.ses.com/media-gallery

SES White papers are available under: https://www.ses.com/news/whitepapers

About SES

SES is the world-leading satellite operator and the first to deliver a differentiated and scalable GEO-MEO offering worldwide, with more than 50 satellites in Geostationary Earth Orbit (GEO) and 12 in Medium Earth Orbit (MEO). SES focuses on value-added, end-to-end solutions in two key business units: SES Video and SES Networks. The company provides satellite communications services to broadcasters, content and internet service providers, mobile and fixed network operators, governments and institutions. SES’s portfolio includes the ASTRA satellite system, which has the largest Direct-to-Home (DTH) television reach in Europe, O3b Networks, a global managed data communications service provider, and MX1, a leading media service provider that offers a full suite of innovative digital video and media services. Further information available at: www.ses.co

__________________________________________________________________________________________________________________________

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 761413

___________________________________________________________________________________________________________________________________________________________________



Contacts

SES
Markus Payer, +352 710 725 500
Corporate Communications & PR
Markus.Payer@ses.com



Permalink : http://me-newswire.net/news/4166/en

GSMA Mobile IoT Initiative Takes off with Multiple Commercial Network Launches around the World

AT&T, China Mobile, China Unicom, China Telecom, Deutsche Telekom, Verizon and Vodafone Launch Mobile IoT (LPWA) Networks

SHANGHAI-Monday, June 26th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- The GSMA today announced that its Mobile IoT Initiative1 has taken off with the launch of multiple commercial rollouts of Low Power, Wide Area (LPWA) solutions by several of the world’s leading mobile operators including AT&T, China Mobile, China Unicom, China Telecom, Deutsche Telekom (DT), Verizon and Vodafone. China Mobile and China Unicom have launched NB-IoT across several key cities with China Telecom launching NB-IoT networks across the country. Vodafone has also launched NB-IoT in Spain and the Netherlands. DT has launched in several cities in Germany and nationwide in the Netherlands. AT&T and Verizon have previously announced nationwide launches of LTE-M technology. In addition to these deployments, the GSMA also announced that its Mobile IoT Innovators programme, which is designed to encourage the development of new LPWA solutions, has reached over 500 members, underscoring the growth of the wider IoT ecosystem.

“The Mobile IoT initiative encouraged the market to adopt licensed LPWA networks and we are now seeing this work come to fruition with multiple commercial deployments around the world, as well as the availability of hundreds of different applications and solutions,” commented Alex Sinclair, Chief Technology Officer, GSMA. “It is clear that the market sees the benefit of adopting solutions that offer flexibility, security, lower costs, and cover all use cases, and we look forward to seeing other operators follow in the near future.”

Mobile operators are enhancing their licensed cellular networks with NB-IoT and LTE-M technologies, which utilise globally agreed 3GPP standards to scale the Internet of Things. These new Mobile IoT networks are designed to support mass-market IoT applications such as smart meters, environmental sensors and consumer electronics, that are low cost, use low data rates, require long battery lives and often operate in remote locations. Both technologies will be further evolved in 3GPP’s Release 15.

China at Forefront in Development of LPWA Market

According to analyst house Gartner, China is set to be one of the leading LPWA markets, accounting for 486 million of the estimated 3.1 billion connections globally by 2025. It is also at the forefront in the global development of Mobile IoT in terms of both network launches and a record number of ecosystem developer partners. China Mobile has launched NB-IoT networks in several key cities including Yingtan and China Unicom has rolled-out NB-IoT networks in Shanghai, as well as the main urban areas in Guangzhou, Shenzhen and Fuzhou, for a number of different solutions across smart parking, smart fire sensors and smart meters. China Telecom has announced the roll-out of nationwide NB-IoT networks.

China is also leading in the development of new innovative solutions based on Mobile IoT technology as a part of the GSMA’s Mobile IoT Innovator community. Of the 546 global companies currently developing new solutions based on Mobile IoT technology, over 215 are from China. Solutions include smart parking, pet tracking, asset tracking and smart agriculture amongst many others.

Mobile IoT for Social Good

At the GSMA Innovation City, located in the Shanghai New International Expo Centre (SNIEC) in Hall W3 at Mobile World Congress Shanghai, the GSMA will demonstrate how Mobile IoT technologies are supporting the mobile industry’s leadership role in achieving the United Nations Sustainable Development Goals. China Telecom will demonstrate how its environmental monitoring service is helping to keep air quality high and water supplies pure with big data analysis as well as emergency response services (SDG 13: Climate Action). The GSMA will also showcase how Mobile IoT networks are helping the St Andrew’s University Sea Mammal Research Unit to monitor harbour seals and preserve life underwater (SDG 14: Life Below Water). Other demos will include a connected bike, which utilises an NB-IoT network to improve the operation of bike hire schemes, as well as a connected smart waste bin for improved refuse collection from China Unicom. China Mobile will also demonstrate its OneNET platform that can be used for different IoT services such as smart homes, wearable devices or connected cars.

Mobile IoT at Mobile World Congress Shanghai 2017

At Mobile World Congress Shanghai, the GSMA’s Internet of Things programme will host the ‘4th GSMA Global Mobile IoT Summit’ with leading industry experts on Tuesday, 27 June from 13:30 – 18:00. The programme will explore how mobile operators, Mobile IoT customers and the wider ecosystem have successfully deployed Mobile IoT solutions. There will also be a separate session, ‘IoT Summit at MWC Shanghai 2017’, on Thursday, June 29 at 11:30 that brings industry experts together to discuss the IoT opportunity and the many ways in which it will transform everyday life, including subjects such as Low Power Wide Area, IoT security and IoT big data. To register for any of these events, please go to: www.gsma.com/iot/event/mobile-world-congress-shanghai-2017/.

Get Involved at Mobile World Congress Shanghai 2017

For more information on the 2017 Mobile World Congress Shanghai, visit www.mwcshanghai.com. Follow developments and updates on Mobile World Congress Shanghai through our social media channels – follow us on Twitter at @GSMA and use #MWCS17, get regular updates through our LinkedIn Showcase Page at www.linkedin.com/company/mobile-world-congress-shanghai, and follow us on Facebook at www.facebook.com/mwcshanghai. In China, you can follow us on Sina Weibo weibo.com/mwcshanghai or search “GSMA_MWCS” in WeChat. For additional information on GSMA social channels, visit www.mwcshanghai.com/about/contact/social-media.

Notes to Editors

1.) The GSMA Mobile IoT Initiative: The GSMA’s Mobile IoT Initiative is helping to support the industry deliver commercial LPWA solutions in licensed spectrum. It is currently backed by 74 global mobile operators, device makers and chipset, module and infrastructure companies worldwide. In the space of a year it has helped to establish market standards for LPWA, published by 3GPP, that will play a fundamental role in the growth, development and adoption of the technology as well as securely and cost effectively connect the billions of new devices making up the IoT. LPWA networks will be used for a wide variety of applications such as industrial asset tracking, safety monitoring, water and gas metering, smart grids, city parking, vending machines and city lighting. For further information: https://www.gsma.com/iot/mobile-iot-initiative/.

About the GSMA

The GSMA represents the interests of mobile operators worldwide, uniting nearly 800 operators with more than 300 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces industry-leading events such as Mobile World Congress, Mobile World Congress Shanghai, Mobile World Congress Americas and the Mobile 360 Series of conferences.

For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.

Contacts

For GSMA
Ava Lau, +852-2533 9928
alau@webershandwick.com
or
GSMA Press Office
pressoffice@gsma.com


Permalink : http://me-newswire.net/news/4141/en

Leading UAE-based Cybersecurity Company Warns of Dangers of Petya Ransomware and Stresses the Importance of Network Security Assessments & Patching

 Managed FZ-LLC warns of dangers of not patching or conducting VA/PT – offers solutions to support worried and stressed IT Departments and Senior Managers

Dubai, United Arab Emirates -Wednesday, June 28th 2017 [ ME NewsWire ]

Two months after one of the worst ransomware attack in history was conducted via WannaCry, a newer, more dangerous version is out in the wild. Security researchers have called it Petya, and it’s even more devastating than WannaCry.Petya has some of the same characteristics of WannaCry, including using the notorious EternalBlue exploit for Windows. The only difference with Petya is that, according to one well-known security researcher, it is currently spreading over local networks. This threat of a more advanced WannaCry that could be spread through phishing and spammy emails and links should be enough to seriously alarm IT managers.

One of the main reasons as to why WannaCry and now Petya are so successful in their infection is because of unpatched systems. According to KrebsonSecurity, Microsoft did release a patch for EternalBlue exploit in March 2017, but only a few companies took the time to install the patch and update their systems. The many that didn’t were the victims of WannaCry, and now Petya.

Managed FZ-LLC is responsible for making sure that companies large and small in the UAE are not exploited by this new ransomware threat. Managed has been busy helping large customers assess the overall security of their IT infrastructure with theRADIUS VA/PT service, as well as perform packet analysis to see what exactly is going through their networks – in order to ensure a secure IT environment. In addition, Managed sent an alert to its customers via its proprietary Managed Security Threat Advisory service – in advance of mainstream media, so that they can be forewarned and prepared.

The two key ways to ensure that an organization survives these attacks, which are getting worse as time goes by, is to ensure that first, all systems, including servers, client machines, and networking gear have up-to-date patches and second, data backups are made regularly, and data restoration is tested. Companies should also regularlyconduct Vulnerability Assessments and Penetration Tests, to ensure that rogue malware and traffic can’t get into the infrastructure, and that no malicious data can leave unchecked. This should be coupled with frequent user security awareness training exercises.

To learn more about how your business can be protected and prepared for these cybersecurity crises, contact Managed Services now.

ABOUT MANAGED FZ LLC
Managed is a leading provider of innovative solutions in Online Threat Management& Mitigation, Brand Risk Monitoring and Managed Cyber Security Services for high profile Government and private sector organizations. Built around the concept of safeguarding our client’s information and IT infrastructure, we enable our clients to focus on their business growth without worrying about their IT and online security.

Managed’s customer base includes Government organizations, telecom operators and finance, aviation, media and news organizations. Managed’s obsessive focus on customer service is built around its large 24x7x365 NOCSOC and Monitoring Center in Dubai, which provides proactive monitoring and client support services.

Contacts

Ali Adeel,+97143746220

pr@managedservices.me


Permalink : http://me-newswire.net/news/4159/en

'More than Systemic Sclerosis: The Inside Story' – patients reveal the unseen impact of lung fibrosis

INGELHEIM, Germany-Thursday, June 29th 2017 [ ME NewsWire ]

    An online gallery of photo and film showcases uplifting stories of people living with systemic sclerosis (SSc) at www.boehringer-ingelheim.com/respiratory/systemic-sclerosis/inside-story
    Experts call for more public awareness on the disease and about how individuals are affected by SSc
    SSc is a rare disease which mostly affects women in the prime of their lives, involving the skin, lungs and other organs

“The disease wants to throw me down so I resist and do the exact opposite. I love life. But at diagnosis I wanted to give up. I became unable to walk even 20 metres because of the impact of the disease on my lungs. So I learned to fight. I'm very proud of the woman I am.”

– Rute from Portugal, living with systemic sclerosis

(BUSINESS WIRE)-- ‘More than Systemic Sclerosis: The Inside Story’ launches today to mark World Scleroderma Day. This global initiative highlights the importance of understanding the ‘inside story’ of each individual living with systemic sclerosis, and to increase awareness of the potential serious consequences when fibrosis develops in vital organs such as the lungs.

The new photography and film gallery is available at www.boehringer-ingelheim.com/respiratory/systemic-sclerosis/inside-story and features eight patients from seven countries, each telling their story about living with this rare condition.

Systemic sclerosis is a disfiguring, disabling and potentially fatal rare disease that causes scarring (fibrosis) of the skin (also known as ‘scleroderma’) and of major organs, such as the lungs (lung fibrosis).1,2,3 Systemic sclerosis affects an estimated two million people worldwide, mostly women in the prime of their lives between 25 and 55 years of age.3,4,5

"Beneath the visible, external effects of systemic sclerosis, many people with the disease also live with internal organ involvement including lung scarring (fibrosis) that can make it difficult to breathe and perform everyday activities. Patients with lung involvement face an uncertain future as the fibrosis can be debilitating and may become life-threatening,” said Professor Christopher Denton, Consultant Rheumatologist at the Centre for Rheumatology at the Royal Free Hospital and University College London, UK.

This global initiative has been developed by Boehringer Ingelheim, with the support of global and local patient organisations to help share patients’ unique stories. Annelise Rønnow, President of the Federation of European Scleroderma Associations (FESCA) commented: “People living with systemic sclerosis are not defined by their disease. By sharing the stories of real people, this campaign demands that patients are seen for who they really are. We hope that through greater awareness and education, we can better support those affected by the disease so they can aim to lead happy, fulfilling lives.”



The campaign photographer: Alison Romanczuk

‘The Inside Story’ portrait photographs capture the unique personalities of people living with systemic sclerosis (scleroderma). Photographer and sarcoma survivor Alison Romanczuk explains how she approached the project: “There is always more beneath the surface, and I want to invite people to see beyond physical appearances. While identity and body image are important themes to my work, ultimately I'm deeply curious and want to bring personalities and stories to life through the lens.” Alison added, “I hope that these new photographs raise awareness about the disease by showing the true colours of these bright and inspirational individuals.”

Intended audiences

This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and a country-specific press release on this topic may have been issued in the countries where we do business.

For references and notes to editors, please visit: www.boehringer-ingelheim.com/press-release/ssc-inside-story

For more information, please visit: www.boehringer-ingelheim.com/respiratory/ssc-ild

Further media channels

www.facebook.com/boehringeringelheim

www.twitter.com/Boehringer

Contacts

Boehringer Ingelheim
Corporate Communications
Media + PR
Manuela Kabus
Phone: +49 6132 – 77 96121
Fax: +49 6132 – 77 6601
Email: press@boehringer-ingelheim.com





















Permalink : http://www.me-newswire.net/news/4168/en

YuppTV Collaborates with Fox Star Studios to Offer the Most-Awaited Collection of Movies on YuppFlix for Expat Community

YuppTV Users across the Globe Can Now Watch Famous Movies by Fox Star Studios, Including Ae Dil Hai Mushkil, Neerja and More

NEW DELHI-Thursday, June 29th 2017 [ ME NewsWire ]
(BUSINESS WIRE)-- World’s largest player for South-Asian content, YuppTV, announced its partnership with Fox Star Studios, one amongst the leading production houses of today. As part of the non-exclusive association, YuppTV is set to feature an admirable collection of popular movies by the Fox Star Studios, including Ae Dil Hai Mushkil, Jolly LLB2, Akira, MS Dhoni and Neerja, on its on-demand movie streaming platform, YuppFlix, which can be accessed by YuppTV users across the globe for expat community.
Commenting on the association, Mr. Uday Reddy, Founder & CEO of YuppTV, said, “We are glad to announce our association with one of the leading production houses in India and offer the latest collection of movies to our global users. At YuppTV, we have always endeavoured to extend the best linear and on-demand entertainment solutions to our ever-expanding base of global users. The association will enable us to offer the best movie catalogue by Fox Star Studios on our platform. We shall further continue to include the latest movies in our offerings and are affirmative that the users will enjoy the best movie catalogue on YuppFlix.”
YuppTV has been actively updating its offering of latest movies on YuppFlix, its dedicated platform for on-demand movie streaming. Users can access the latest movies on all YuppTV platforms, including the iOS and Android app and internet-enabled devices.
About YuppTV
YuppTV is one of the world’s largest internet-based TV and On-demand service providers for South Asian content, offering more than 250+ TV channels, 5000+ Movies and 100+ TV Shows in 14 languages. YuppTV recently received funding from Emerald Media, a Pan-Asian platform established by leading global investment firm KKR for investing in the media and entertainment sector, wherein Emerald Media acquired a significant minority stake in the company for US$50mn. Emerald Media is led by industry veterans Rajesh Kamat and Paul Aiello, supported by an experienced team of investment and operating executives. The platform primarily focuses on providing growth capital to media, entertainment and digital media companies. YuppTV had earlier raised its Series A round of funding from Poarch Creek Indian Tribe of Alabama.
YuppTV has 25000 hours of entertainment content catalogued in its library, while nearly 2500 hours of new on-demand content is added to the YuppTV platform every day. YuppTV offers Live TV and Catch-Up TV technology. It also offers YuppFlix, a movie on demand streaming service for Expat Market, and recently launched YuppTV Originals to bring forth unconventional story telling in collaboration with the top talent from the movie industry. Originals will be available in episodic format for the digital audience, exclusively on YuppTV’s platform. YuppTV is currently ranked #1 Internet Pay TV platform for South Asians living abroad and the largest Internet TV platform from premium content availability in India. YuppTV is the most downloaded Indian SmartTV app and it also boasts of 13 million mobile downloads with 4.0 user rating.
Visit www.yuppflix.com for more information.
Contacts
YuppTV
Pooja Diwan, +91 40 23555055

Permalink : http://me-newswire.net/news/4165/en

Toshiba Memory Corporation to Invest in Manufacturing Facilities for Fab 6 at Yokkaichi Operations

TOKYO -Wednesday, June 28th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- Toshiba Corporation (TOKYO:6502) today announced that its board of directors, meeting today, has agreed upon a FY2017 investment program for its wholly owned subsidiary, Toshiba Memory Corporation (TMC), that will channel approximately 180 billion yen into Fab 6 at Yokkaichi Operations, TMC’s Flash memory facility. The investment will cover installation of manufacturing facilities in Phase-1 of the fab, and the construction of Phase-2.

Production at Fab 6 will be entirely devoted to BiCS FLASH™, Toshiba's innovative 3D Flash memory. As detailed in Toshiba’s February 9, 2017 announcement “Toshiba Starts Construction of Fab 6 and Memory R&D Center at Yokkaichi, Japan”, Phase-1 of the fab is scheduled for completion in summer 2018, and the current round of investment will ensure this target date is met. Demand for Flash memory is expected to see continued strong growth from data centers and enterprise servers, which will accelerate demand for 3D Flash memories. This understanding guided the board in making today’s decision.

The investment in Fab 6 will enable TMC to install manufacturing equipment for 96-layer 3D Flash memories, including deposition and etching equipment. In parallel with this, construction of Phase-2 of Fab 6 is scheduled to start in September this year, with a completion target of the end of 2018. Specific production capabilities and schedules will be aligned with market demand.

TMC has recently asked SanDisk, its partner in joint ventures for investment in manufacturing equipment at TMC’s Yokkaichi Operations, to clarify whether it intends to jointly invest in the Fab 6 facility. If SanDisk does not agree to such joint investment, TMC will invest alone in manufacturing equipment for separate TMC capacity.

The investment decided today is included in the three year investment plan of 360 billion yen announced on March 17, 2016 “Notice of Construction of New Semiconductor Fabrication Facility.”

About Toshiba

Founded in Tokyo in 1875, Toshiba Corporation is a Fortune Global 500 company that contributes to a better world and better lives with innovative technologies in Energy, Infrastructure and Storage. Guided by the philosophy of “Committed to People, Committed to the Future,” Toshiba promotes operations through a global network of 551 consolidated companies employing 188,000 people, with annual sales surpassing 5.6 trillion yen (US$50 billion; March 31, 2016).

Find out more about Toshiba at www.toshiba.co.jp/index.htm



Contacts

Press Contact
Toshiba Corporation
Kaori Hiraki, +81-3-3457-2100
Public Relations & Investor Relations Div.
Media Relations Group
media.relations@toshiba.co.jp



Permalink : http://me-newswire.net/news/4161/en

Toshiba Memory Corporation Announces 96-Layer 3D Flash Memory

Fourth Generation Toshiba Memory Corporation BiCS FLASH™ adds layers, boosts capacity

TOKYO-Wednesday, June 28th 2017 [ ME NewsWire ]
(BUSINESS WIRE)-- Toshiba Memory Corporation, the world leader in memory solutions, today announced that it has developed a prototype sample of 96-layer BiCS FLASH™ three-dimensional (3D) flash memory with a stacked structure[1], with 3-bit-per-cell (triple-level cell, TLC) technology. Samples of the new 96-layer product, which is a 256 gigabit (32 gigabytes) device, are scheduled for release in the second half of 2017 and mass production is targeted for 2018. The new device meets market demands and performance specifications for applications that include enterprise and consumer SSD, smartphones, tablets and memory cards.
Going forward, Toshiba Memory Corporation will apply its new 96-layer process technology to larger capacity products, such as 512 gigabit (64 gigabytes) and 4-bit-per-cell (quadruple-level cell, QLC) technology, in the near future.
The innovative 96-layer stacking process combines with advanced circuit and manufacturing process technology to achieve a capacity increase of approximately 40% per unit chip size over the 64-layer stacking process. It reduces the cost per bit, and increases the manufacturability of memory capacity per silicon wafer.
Since announcing the world’s first[2] prototype 3D flash memory technology in 2007, Toshiba Memory Corporation has continued to advance development of 3D flash memory and is actively promoting BiCS FLASH™ to meet demand for larger capacities with smaller die sizes.
This 96-layer BiCS FLASH™ will be manufactured at Yokkaichi Operations in Fab 5, the new Fab 2, and Fab 6, which will open in summer 2018.
Note:
1. A structure stacking flash memory cells vertically on a silicon substrate to realize significant density improvements over planar NAND flash memory, where cells are formed on the silicon substrate.
2. Source: Toshiba Memory Corporation, as of June 12, 2007.
* Company names, product names, and service names mentioned herein may be trademarks of their respective companies.
Contacts
Toshiba Memory Corporation
Kota Yamaji, +81-3-3457-3473
Business Planning Division
semicon-NR-mailbox@ml.toshiba.co.jp

Permalink : http://me-newswire.net/news/4152/en


 

Wednesday, June 28, 2017

Rimini Street Recognized Again as a “Top Workplace” by Bay Area News Group

 Employee survey cited corporate culture, work environment, communication policies and employee benefits among reasons why Company selected as “Top Workplace”

LAS VEGAS -Wednesday, June 28th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- Rimini Street, Inc., a global provider of enterprise software products and services, and the leading independent support provider for Oracle and SAP products, today announced that it has been named one of the 2017 Bay Area “Top Workplaces” by the Bay Area News Group, for the fourth time. The Top Workplaces program recognizes Bay Area employers based on employee surveys conducted by WorkplaceDynamics, LLC, a leading research firm on organizational health and employee engagement.

The WorkplaceDynamics employee survey asks participants a series of questions to uncover a comprehensive view into a company’s organizational health. Participants are asked about their employer’s culture and work ethic, communication policies, pay and benefits. Participants are also given the opportunity to provide additional comments and insightful feedback on their organization’s culture and environment.

Over 4,000 organizations participate in the WorkplaceDynamics study each year, with more than one million participants completing the employee surveys.

“Rimini Street is honored to receive recognition from our employees as a top workplace once again,” said Jim Petraglia, group vice president, Global HR & Shared Services, Rimini Street. “Rimini Street is passionate about recruiting the best talent, creating an environment that allows experienced professionals to thrive and grow in a team-oriented culture, sharing its success through industry-leading compensation and benefits, and delivering exceptional service and value to our clients.”

The Bay Area News Group published the complete list of Top Workplaces on June 25th. For more information about the Top Workplaces list and WorkplaceDynamics, please visit www.topworkplaces.com and www.workplacedynamics.com.

About Rimini Street, Inc.

Rimini Street is a global provider of enterprise software products and services, and the leading independent support provider for Oracle and SAP products. The company has redefined enterprise support services since 2005 with an innovative, award-winning program that enables licensees of IBM, Microsoft, Oracle, SAP and other enterprise software vendors to save up to 90 percent on total support costs. Clients can remain on their current software release without any required upgrades for a minimum of 15 years. Nearly 1,300 global Fortune 500, midmarket, public sector and other organizations from a broad range of industries currently rely on Rimini Street as their trusted, independent support provider. To learn more, please visit http://www.riministreet.com, follow @riministreet on Twitter and find Rimini Street on Facebook and LinkedIn.

Forward-Looking Statements

This press release may contain forward-looking statements. The words “believe,” “may,” “will,” “plan,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to risks and uncertainties, and are based on various assumptions. If the risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. Rimini Street assumes no obligation to update any forward-looking statements or information, which speak only as of the date of this press release.

© 2017 Rimini Street, Inc. All rights reserved. “Rimini Street” is a registered trademark of Rimini Street, Inc. in the United States and other countries, and Rimini Street, the Rimini Street logo, and combinations thereof, and other marks marked by TM are trademarks of Rimini Street, Inc. All other trademarks remain the property of their respective owners, and unless otherwise specified, Rimini Street claims no affiliation, endorsement, or association with any such trademark holder or other companies referenced herein.

Contacts

Rimini Street, Inc.
Michelle McGlocklin, +1 925-264-6579
mmcglocklin@riministreet.com






















Permalink : http://www.me-newswire.net/news/4158/en

China and India to Account for Half of All New Mobile Subscribers Added by 2020, Finds New GSMA Study

Asia Pacific Mobile Economy Valued at $1.3 Trillion – Accounting for 5.2 Per Cent of GDP

SHANGHAI -Wednesday, June 28th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- China and India will account for almost half of all new mobile subscribers expected to be added worldwide by the end of the decade, according to a new GSMA study. The 2017 edition of the GSMA’s ‘Mobile Economy: Asia Pacific’ report, published today at Mobile World Congress Shanghai, forecasts that India will account for 27 per cent (206 million) and China 21 per cent (155 million) of the approximately 753 million new mobile subscribers expected to be added globally by the end of 2020. The Asia Pacific region as a whole is forecast to increase from 2.7 billion unique mobile subscribers1 at the end of 2016 to 3.1 billion in 2020, accounting for two-thirds of global growth. The report also highlights how the region’s mobile industry will be a growing contributor to the Asia’s economy and social development over this period – and also play a pioneering role in 5G.

“Led by India and China, Asia’s mobile industry will be the main engine of global subscriber growth for the remainder of the decade, connecting almost half a billion new customers across the region by 2020,” said Mats Granryd, Director General of the GSMA. “We are also seeing a dramatic shift to mobile broadband networks, particularly 4G, which is providing a platform for a rich range of innovative new services across both developed and emerging markets in the region. Meanwhile, advanced operators in Asia are set to become among the first in the world to launch commercial 5G networks before the end of the decade.”

Asia Leading the Move to 5G
Subscriber growth in the Asia Pacific region will mean that mobile penetration in the region (as a percentage of the population) will grow from 66 per cent in 2016 to 75 per cent in 2020. However, the diverse nature of the region means that mobile penetration rates vary widely. Asia is home to four of the top five most penetrated markets in the world (Hong Kong, Japan, Singapore and Taiwan), but also some of the least penetrated, such as North Korea.

Mobile broadband (3G and above) is now the dominant technology in the region, accounting for more than half of connections for the first time last year. The study notes that Asian markets such as China, Japan and South Korea are also driving the development of 5G mobile technologies. 5G connections (excluding IoT) are anticipated to reach 670 million in Asia Pacific by 2025, accounting for just under 60 per cent of global 5G connections by that point.

Mobile Driving Economic Growth and Delivering the SDGs
Mobile technologies and services contributed $1.3 trillion in economic value to the Asia Pacific economy last year, equivalent to 5.2 per cent of regional Gross Domestic Product (GDP)2. It is forecast that this contribution will increase to $1.6 trillion (5.4 per cent of GDP) in 2020 as countries benefit from the improvements in productivity and efficiency brought about by increased take-up of mobile services and adoption of new mobile technologies such as machine-to-machine (M2M).

Asia’s mobile ecosystem also supported approximately 16 million jobs in 2016, directly and indirectly, and made a substantial contribution to the funding of the public sector. It is estimated that the ecosystem made a tax contribution to the public finances of the region’s governments of around $166 billion last year.

The report highlights the major shift in consumer behavior underway in Asia Pacific, triggered by rising smartphone and mobile internet adoption, improved affordability, and the increasing availability on locally relevant content. This has led to a boom in mobile services in areas such as video, social media, e-commerce and financial services. Mobile internet penetration in Asia Pacific has doubled over the last five years, reaching approximately half of the regional population by the end of 2016.

Asia’s mobile industry is also playing a key role in tackling various social and economic challenges as outlined by the United Nations Sustainable Development Goals (SDGs) 3. The report highlights several case studies where mobile services are helping to eliminate poverty; improving health, education, gender equality and employment opportunities; helping to deliver safer cities; and addressing climate change and other issues.

“The mobile ecosystem in Asia is evolving rapidly, leading to the emergence of new services and applications that are transforming the way citizens across this diverse region live, work, play and communicate,” added Granryd. “To fully harness mobile’s power to drive measurable economic, social and cultural value, we urge governments and policymakers to collaborate with the mobile industry to develop robust and progressive digital ecosystems, supported by forward-looking regulatory frameworks.”

The new report ‘The Mobile Economy: Asia Pacific 2017’ is authored by GSMA Intelligence, the research arm of the GSMA. To access the full report and related infographics, please visit: www.gsma.com/mobileeconomy/asiapacific/.

-ENDS-

About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting nearly 800 operators with more than 300 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces industry-leading events such as Mobile World Congress, Mobile World Congress Shanghai, Mobile World Congress Americas and the Mobile 360 Series of conferences.

For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.
______________________________
1 A unique mobile subscriber represents an individual that can account for multiple SIM connections. There were 4.2 billion SIM connections in the Asia Pacific region at the end of 2016, forecast to rise to 5.1 billion by the end of 2020.
2 GDP contribution includes direct ecosystem contribution (1.6%); indirect contribution (0.6%); and productivity improvements (3.0%).
3 The United Nations member states adopted a set of 17 Sustainable Development Goals (SDGs) in September 2015. The SDGs set a number of targets, including ending poverty, halting climate change, and fighting injustice and inequality, by 2030. http://www.gsma.com/betterfuture/



Contacts

Media Contacts:
For the GSMA
Chloe Lee/ Yan Zhao
+86 10 8569 9928 / +86 10 8569 9901
CLee4@webershandwick.com / yzhao@webershandwick.com
or
Ava Lau
+852 2533 9928
alau@webershandwick.com
or
Clare Fenny
+44 20 7067 0749
CFenny@webershandwick.com
or
GSMA Press Office
pressoffice@gsma.com



Permalink : http://me-newswire.net/news/4156/en

New Study from GSMA and CAICT Forecasts That China Will Be the World’s Largest 5G Market by 2025

China to Account for 39 Per Cent of Global 5G Market by 2025

SHANGHAI-Wednesday, June 28th 2017 [ ME NewsWire ]
(BUSINESS WIRE)-- Chinese operators are on track to launch commercial 5G networks by 2020 and are expected to establish China as the world’s largest 5G market by 2025, according to a new study by GSMA Intelligence and the China Academy of Information and Communications Technology (CAICT). The new study ‘5G in China: Outlook and Regional Comparisons’, which was published today at GSMA Mobile World Congress Shanghai, explores the near-term outlook for the testing and commercial launches of new 5G networks in China and other advanced Asia markets, and the potential 5G use cases for both the consumer and enterprise markets.
“Operators in China are collaborating closely with government and enterprises to launch what will become one of the largest 5G deployments in the world,” said Mats Granryd, Director General of the GSMA. “In its early phase, 5G will offer an enhanced mobile broadband experience that will enable next-generation consumer services such as augmented and virtual reality, while at the same supporting mission-critical applications across a range of industry verticals.”
China Prepares World’s Largest 5G Deployment
Mobile operators in China plan to run a phased testing period for 5G networks from 2017 to 2019 before launching commercially in 2020. Following commercial deployment, it is forecast that 5G connections in China will reach 428 million by 2025, accounting for 39 per cent of the 1.1 billion global 5G connections expected by that point.
Chinese operators are expected to deploy ‘standalone’ 5G networks, which will require the construction of new base stations to site 5G equipment, backhaul links and a core network. However, the report notes that another option being considered in several other Asia markets is to deploy ‘non-standalone’ 5G networks that would run on existing infrastructure supplemented by targeted small cell deployment in areas of high density, allowing 4G and 5G services to run in parallel.
4G penetration is China has increased fivefold to 61 per cent over the two-year period to March 2017 and there remains significant headroom for 4G growth. As a result, 4G and 5G networks are expected to co-exist in China for a considerable period of time. The rate of 5G network rollout and adoption in China is also expected to be slower than it was for 4G, which Chinese operators were able to deploy rapidly earlier this decade within a mature 4G ecosystem. On capex, indications from the Chinese mobile operators are that 5G investment will follow a more gradual path and over a longer timeframe than 4G, roughly seven years, from 2018 to 2025 – with capex not expected to account for more than 25 per cent of operator revenue prior to commercial launch.
5G Delivering New Consumer Services and Transforming the Enterprise
In their early phase, 5G networks will concentrate on boosting the capacity of 4G networks to support rising cellular data traffic demands. 5G will also enable enhanced mobile broadband (eMBB) services such as 4K/8K Ultra-HD video and augmented reality (AR) and virtual reality (VR) applications. Although some services will require devices with new form factors, the smartphone is expected to remain the principal 5G interface at launch. The first 5G smartphones are likely to be priced at a premium to 4G models, as they will require an enhanced chipset and RF module supporting multiple sub-6 GHz, and possibly extremely high frequency bands (mmWave), as well as, potentially, a 4K or 8K screen.
Meanwhile, it is the enterprise space that is considered to offer operators the largest incremental revenue opportunity. Operators are collaborating with the broader mobile ecosystem and vertical industry players to develop new services and business models that will utilise 5G networks. 5G will support applications that require massive scale or are mission-critical and therefore demand low latency. Key vertical markets for 5G applications include automotive and transport, logistics, energy and utilities monitoring, security, finance, healthcare, industrial, and agriculture.
The new report ‘5G in China: Outlook and Regional Comparisons’ is co-authored by GSMA Intelligence, the research arm of the GSMA, and the China Academy of Information and
Communications Technology (CAICT). The report is available to download in English and Chinese language versions.
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting nearly 800 operators with more than 300 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces industry-leading events such as Mobile World Congress, Mobile World Congress Shanghai, Mobile World Congress Americas and the Mobile 360 Series of conferences.
For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.
Contacts
For the GSMA
Chloe Lee/ Yan Zhao
+86 10 8569 9928 / +86 10 8569 9901
CLee4@webershandwick.com / yzhao@webershandwick.com
or
Ava Lau
+852 2533 9928
alau@webershandwick.com
or
Clare Fenny
+44 20 7067 0749
CFenny@webershandwick.com
or
GSMA Press Office
pressoffice@gsma.com

Permalink : http://me-newswire.net/news/4157/en

Ekimetrics Official Partner of Facebook Portal Dedicated to MMM (Marketing Mix Modeling)

 The French global analytics consultancy was chosen as a trusted third-party dedicated to increasing the reliability of advertising performance metrics on Facebook networks

PARIS -Tuesday, June 27th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- Ekimetrics (www.ekimetrics.com), a leading practitioner in data analytics and marketing intelligence for over 10 years, has announced that they are joining the Marketing Mix Modeling Program.

The companies who are part of the Facebook MMM Partner Program focus on measuring advertising’s impact on Facebook, Instagram and Facebook Audience Network. Advertisers need to measure the outcomes of their media investments, and identify correlations between their brand and an impact on their sales.

Ekimetrics will enable advertisers to acquire a better understanding of their media mix in different channels. They will be able to compare the effectiveness of offline/online investments with the kind of accuracy that has been expected for a long time.

Measuring digital and social ROI: accuracy and granularity at a level never achieved before

Ekimetrics will offer a solution for measuring the unique market ROI, which will be able to quantitatively measure the impact of advertising investments on sales and on the brand, as well as compare investments between different social networks with a granularity by category, product, country and content that is well above current practices.

Ekimetrics is recognized for its strong industry knowledge and disruptive approaches. Facebook teams audited Ekimetrics’ methods in depth before choosing the company among the first partners. This French nugget has now become a key provider for Marketing, Insights and Media Managers internationally (Asian social platforms such as Baidu, Wechat... will also be included). Ekimetrics will also participate in developing new solutions to continuously enhance the world leader’s commitment to transparency.

Quentin Michard, CEO Ekimetrics UK/HK and Manager of the partnership with Facebook: The fact that Facebook has chosen us is a recognition of our unique expertise in marketing ROI thanks to innovative methodologies. This will be a great opportunity for our customers and partners to bring tangible enhancements to measuring digital and social ROI, breaking with traditional and still very incomplete allocation methods. This is also the result of 10 years of experience in data, and of our philosophy which, from the start, has always been to combine human and technological intelligence.

About Ekimetrics: www.ekimetrics.com
Founded in 2006, Ekimetrics is an global analytics consultancy, leading practitioner in data analytics and marketing intelligence. Ekimetrics optimizes business strategies through innovative statistical methods. A pioneer in data science and a leader in its market in France and in Europe. The company now has projects in over 40 countries with 5 offices in Paris, London, New York, Hong-Kong and Dubai.
The team of 150 consultants creates customized approaches that can answer the most complex business questions, in such varied industries as automotive, luxury, cosmetics, telecommunications, distribution...
Ekimetrics is unique in its approach combining human intelligence, data and technology. The diversity of profiles - both consultants and statisticians - results in deliverables that are very trade- or business- oriented, unique in the market, and with a focus on ROI.

Contacts

Ekimetrics
Press Contact
MEIJI COMMUNICATION
Sandra Laberenne, +33 6.43.19.13.88
slaberenne@Meiji-communication.com

Permalink : http://me-newswire.net/news/4149/en

Bionext Launches Biosight: an Online Platform That Will Revolutionize Pharmaceutical Research

 Helps companies accelerate the development of new medications by reducing the failure rate during the clinical phase

STRASBOURG, France-Thursday, June 22nd 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- Bionext, a bioinformatics company, announces today the launch of BioSight, an online bio-simulation platform designed for efficient identification of possible side effects of potential drug treatments on the human body. As result of fifteen years of molecular biology R&D, BioSight uses a patented algorithm that is able to predict all of the potential biological targets that are at risk of interacting with a potential drug treatment. Available as Software as a Service (SaaS) or on-site, BioSight, at an affordable price and within a few hours, enables pharmaceutical and biomedical research professionals to better develop their molecules, reduce the failure rate during the clinical trial phase and, therefore, optimize their return on investment.

3.975 billion dollars per drug

That is the average total cost of R&D needed for pharmaceutical companies to launch a new drug on the world market.1 According to LEEM, out of 10,000 target molecules, 10 will become part of patents filed and only one of those will become part of a new drug being sold. The failure rate of drug candidates is particularly high and drug research is primarily abandoned late in the R&D process and advanced stages of clinical research when side effects are most likely to become apparent. These failures typically cost upwards of hundreds of millions of dollars.

It is also estimated that around 85% of these failures occur due to biological reasons linked to problems of effectiveness or toxicity caused by interactions between the drug and targets different than the one the drug is being developed for.

Digital technologies for accelerating therapeutic innovations

With its BioSight platform, Bionext’s ambition is to completely change the current process of developing and making medications- all thanks to digital technology. Goal: lower the entry cost to the therapeutic innovation market by offering thousands of small companies, laboratories and researchers with access to technologies that were previously out of their reach.

In order to accelerate the development of BioSight and to strengthen its position in the bioinformatics market, Bionext hopes to raise more than 5 million Euros in funding over the next 18 months.

1 How Much Does Pharmaceutical Innovation Cost? Forbes, 2013

Contacts

Yucatan for Bionext
Caroline Prince
+33-1-53-63-27-35
bionext@yucatan.fr

Permalink : http://www.me-newswire.net/news/4124/en

SES and MDA Announce First Satellite Life Extension Agreement

 SES to be first customer for on-orbit satellite refuelling service and have more flexibility, resiliency in fleet management

LUXEMBOURG-Wednesday, June 28th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- SES (Euronext Paris:SESG) (LuxX:SESG) and MDA, a global communications and information company, announced today an agreement for an initial satellite life extension mission using an on-orbit refuelling vehicle being built by SSL, a US based subsidiary of MDA and a leading provider of innovative satellites and spacecraft systems.

SES will be the first commercial customer to benefit from the satellite refuelling service, and will be able to activate the service whenever required with minimal disruption to spacecraft operation. The agreement also includes an option for further life extension missions.

SES will work with a new venture, Space Infrastructure Services (SIS), which will commercialise sophisticated satellite servicing capabilities. SIS has contracted SSL to design and build the highly-capable satellite servicing spacecraft vehicle to meet the needs of the US Defense Advanced Research Projects Agency (DARPA)’s Robotic Servicing of Geosynchronous Satellites (RSGS) programme, which is designed to inspect, repair, relocate and augment geosynchronous satellites and plans to include a refuelling payload to extend the life of satellites that are low on propellant.

“Satellite in-orbit servicing is of upmost importance to next-generation architectures for communications satellites. It enables satellite operators like us to have more flexibility in managing our fleet and meeting our customers’ demands,” said Martin Halliwell, Chief Technology Officer at SES. “After witnessing the due diligence of SSL’s and MDA’s technical expertise, we are confident that its new venture is the best partner in the refuelling mission field, and will be able to help SES get more value out of an on-orbit satellite.”

“As a pioneer in next-generation fleet capabilities, SES is clearly committed to improving the space and satellite ecosystem,” said Howard L. Lance, President and CEO at MDA. “We are very pleased to have this refuelling contract with SES and are excited to provide them with more options in fleet management.”

The satellite servicing spacecraft vehicle is planned for launch in 2021.

Follow us on:

Twitter: https://twitter.com/SES_Satellites

LinkedIn: https://www.linkedin.com/company/ses

Facebook: https://www.facebook.com/SES.Satellites

YouTube: http://www.youtube.com/SESVideoChannel

Blog: https://www.ses.com/news/blogs

Media Gallery: https://www.ses.com/media-gallery

SES White papers are available under: https://www.ses.com/news/whitepapers

About SES

SES is the world-leading satellite operator and the first to deliver a differentiated and scalable GEO-MEO offering worldwide, with more than 50 satellites in Geostationary Earth Orbit (GEO) and 12 in Medium Earth Orbit (MEO). SES focuses on value-added, end-to-end solutions in four key market verticals (Video, Enterprise, Mobility and Government). It provides satellite communications services to broadcasters, content and internet service providers, mobile and fixed network operators, governments and institutions, and businesses worldwide. SES’s portfolio includes the ASTRA satellite system, which has the largest Direct-to-Home (DTH) television reach in Europe, and O3b Networks, a global managed data communications service provider. Another SES subsidiary, MX1, is a leading media service provider and offers a full suite of innovative digital video and media services. Further information available at: www.ses.com

About SSL MDA Holdings

SSL MDA Holdings Inc. is a wholly owned subsidiary of MacDonald, Dettwiler and Associates Ltd. (MDA) and serves as the operating company for all MDA businesses.

About MDA

MDA is a global communications and information company providing operational solutions to commercial and government organisations worldwide. MDA’s business is focused on markets and customers with strong repeat business potential, primarily in the Communications sector and the Surveillance and Intelligence sector. In addition, the Company conducts a significant amount of advanced technology development. MDA’s established global customer base is served by more than 4,800 employees operating from 15 locations in the United States, Canada, and internationally. The company’s common shares trade on the Toronto Stock Exchange (TSX:MDA).

About SSL

Space Systems Loral (SSL) is a leading provider of commercial satellites with broad expertise to support satellite operators and innovative space related missions. The company designs and manufactures spacecraft for services such as direct-to-home television, video content distribution, broadband internet, mobile communications, and Earth observation. As a Silicon Valley innovator for 60 years, SSL’s advanced product line also includes state-of-the-art small satellites, and sophisticated robotics and automation solutions for remote operations. For more information, visit www.sslmda.com.

Contacts

Markus Payer
Corporate Communications
Tel. +352 710 725 500
Markus.Payer@ses.com

Takeda and Seattle Genetics Announce Positive Results from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma

 -Randomized Phase 3 Clinical Trial with ADCETRIS Met Primary Endpoint, Demonstrating a Statistically Significant Improvement in Modified Progression-Free Survival-

-Abstract to be Submitted for Presentation at the 2017 ASH Annual Meeting; Regulatory Submissions Planned-

-Seattle Genetics to Host Conference Call and Webcast Today at 8:30 a.m. ET-

CAMBRIDGE, Mass., OSAKA, Japan & BOTHELL, Wash.-Tuesday, June 27th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that the Phase 3 ECHELON-1 clinical trial met its primary endpoint of a statistically significant improvement in modified progression-free survival (PFS) versus the control arm. ECHELON-1 is a randomized, multicenter trial evaluating ADCETRIS (brentuximab vedotin) as part of a frontline combination chemotherapy regimen in 1,334 patients with previously untreated advanced classical Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed to CD30, a defining marker of classical Hodgkin lymphoma. ADCETRIS is currently not approved as a frontline therapy for Hodgkin lymphoma.

Patients in ECHELON-1 were randomized to receive either a combination of ADCETRIS+AVD (Adriamycin, vinblastine, dacarbazine) or ABVD (Adriamycin, bleomycin, vinblastine, dacarbazine), a recognized standard of care for frontline Hodgkin lymphoma. The results of the ECHELON-1 trial demonstrated that combination treatment with ADCETRIS resulted in a statistically significant improvement in modified PFS versus the control arm as assessed by an Independent Review Facility (hazard ratio=0.770; p-value=0.035). The two-year modified PFS rate for patients in the ADCETRIS arm was 82.1 percent compared to 77.2 percent in the control arm. Interim analysis of overall survival (OS), the key secondary endpoint, also trended in favor of the ADCETRIS+AVD arm. An abstract will be submitted for data presentation at the American Society of Hematology (ASH) annual meeting, December 9-12, 2017, in Atlanta, Ga.

The safety profile of ADCETRIS+AVD in the ECHELON-1 trial was consistent with that known for the single-agent components of the regimen. There was an increased incidence of febrile neutropenia and peripheral neuropathy in the ADCETRIS+AVD arm. Febrile neutropenia was reduced through the use of prophylactic growth factors in a subset of patients, and peripheral neuropathy was managed through dose modifications. The control arm had an increased rate and severity of pulmonary toxicity.

“We are excited about the positive result which shows a statistically significant improvement in the primary endpoint of modified PFS,” said Dirk Huebner, M.D., Executive Medical Director, Oncology Therapeutic Area Unit, Takeda Pharmaceutical Company. “The results of this trial signify an important step forward in the development of ADCETRIS and have the potential to change the treatment approach of frontline advanced Hodgkin lymphoma.”

“The outcome of the Phase 3 ECHELON-1 trial represents a significant milestone for the Hodgkin lymphoma community,” said Clay Siegall, Ph.D., President and Chief Executive Officer of Seattle Genetics. “Seattle Genetics’ goal is to establish ADCETRIS as the foundation of care for CD30-expressing lymphomas, including Hodgkin lymphoma. Notably, this is the first clinical trial in frontline advanced Hodgkin lymphoma to show superior efficacy of a regimen that eliminates bleomycin.”

Takeda and Seattle Genetics plan to submit these results to regulatory authorities for approval in their respective territories.

ECHELON-1 Phase 3 Clinical Trial Design

The randomized, open-label, Phase 3 trial is investigating ADCETRIS+AVD versus ABVD as frontline therapy in patients with advanced classical Hodgkin lymphoma. The primary endpoint is modified progression-free survival per Independent Review Facility assessment using the Revised Response Criteria for Malignant Lymphoma. Modified PFS is defined as the time to progression, death or receipt of additional anticancer therapy for patients who are not in complete response after completion of frontline therapy per Independent Review Facility. This endpoint was chosen as it provides a clearer picture of the efficacy of frontline chemotherapy and eliminates the confounding impact of salvage and consolidation chemotherapies and radiotherapy. Secondary endpoints include overall survival, complete remission and safety. The multi-center trial was conducted in North America, Europe, South America, Australia, Asia and Africa. The study enrolled 1,334 patients who had a histologically-confirmed diagnosis of Stage III or IV classical Hodgkin lymphoma and had not been previously treated with systemic chemotherapy or radiotherapy. The ECHELON-1 trial is being conducted under a Special Protocol Assessment (SPA) agreement from the U.S. Food and Drug Administration (FDA) and the trial also received European Medicines Agency (EMA) scientific advice.

Please see Important Safety Information at the end of this press release.

Seattle Genetics Conference Call Details

Seattle Genetics' management will host a conference call and webcast to discuss this announcement. The event will be held today at 5:30 a.m. Pacific Time (PT) / 8:30 a.m. Eastern Time (ET). The live event will be available from Seattle Genetics' website at http://www.seattlegenetics.com, under the Investors section, or by calling 877-723-9521 (domestic) or 719-325-2138 (international). The access code is 9916080. A replay of the discussion will be available beginning at approximately 8:30 a.m. PT / 11:30 a.m. ET today from Seattle Genetics' website or by calling 888-203-1112 (domestic) or 719-457-0820 (international), using access code 9916080. The telephone replay will be available until 5:00 p.m. PT / 8:00 p.m. ET Wednesday, June 28, 2017.

About Classical Hodgkin Lymphoma

Lymphoma is a general term for a group of cancers that originate in the lymphatic system. There are two major categories of lymphoma: Hodgkin lymphoma and non-Hodgkin lymphoma. Classical Hodgkin lymphoma is distinguished from other types of lymphoma by the presence of one characteristic type of cell, known as the Reed-Sternberg cell. The Reed-Sternberg cell expresses CD30.

About ADCETRIS

ADCETRIS is being evaluated broadly in more than 70 clinical trials in CD30-expressing lymphomas, including three Phase 3 studies: the completed ECHELON-1 trial in frontline classical Hodgkin lymphoma, the completed ALCANZA trial in cutaneous T-cell lymphoma, and the ongoing ECHELON-2 trial in frontline mature T-cell lymphomas.

ADCETRIS is an ADC comprising an anti-CD30 monoclonal antibody attached by a protease-cleavable linker to a microtubule disrupting agent, monomethyl auristatin E (MMAE), utilizing Seattle Genetics’ proprietary technology. The ADC employs a linker system that is designed to be stable in the bloodstream but to release MMAE upon internalization into CD30-expressing tumor cells.

ADCETRIS for intravenous injection has received approval from the FDA for three indications: (1) regular approval for the treatment of patients with classical Hodgkin lymphoma after failure of autologous hematopoietic stem cell transplantation (auto-HSCT) or after failure of at least two prior multi-agent chemotherapy regimens in patients who are not auto-HSCT candidates, (2) regular approval for the treatment of classical Hodgkin lymphoma patients at high risk of relapse or progression as post-auto-HSCT consolidation, and (3) accelerated approval for the treatment of patients with systemic anaplastic large cell lymphoma (sALCL) after failure of at least one prior multi-agent chemotherapy regimen. The sALCL indication is approved under accelerated approval based on overall response rate. Continued approval for the sALCL indication may be contingent upon verification and description of clinical benefit in confirmatory trials. Health Canada granted ADCETRIS approval with conditions for relapsed or refractory Hodgkin lymphoma and sALCL.

ADCETRIS was granted conditional marketing authorization by the European Commission in October 2012 for two indications: (1) for the treatment of adult patients with relapsed or refractory CD30-positive Hodgkin lymphoma following autologous stem cell transplant (ASCT), or following at least two prior therapies when ASCT or multi-agent chemotherapy is not a treatment option, and (2) the treatment of adult patients with relapsed or refractory sALCL.

In June 2016, the European Commission extended the current conditional approval of ADCETRIS and approved ADCETRIS for the treatment of adult patients with CD30-positive Hodgkin lymphoma at increased risk of relapse or progression following ASCT.

ADCETRIS has received marketing authorization by regulatory authorities in 67 countries for relapsed or refractory Hodgkin lymphoma and sALCL. See important safety information below.

Seattle Genetics and Takeda are jointly developing ADCETRIS. Under the terms of the collaboration agreement, Seattle Genetics has U.S. and Canadian commercialization rights and Takeda has rights to commercialize ADCETRIS in the rest of the world. Seattle Genetics and Takeda are funding joint development costs for ADCETRIS on a 50:50 basis, except in Japan where Takeda is solely responsible for development costs.

ADCETRIS (brentuximab vedotin) Global Important Safety Information

CONTRAINDICATIONS

ADCETRIS is contraindicated for patients with hypersensitivity to brentuximab vedotin and its excipients. In addition, combined use of ADCETRIS with bleomycin is contraindicated as it causes pulmonary toxicity.

SPECIAL WARNINGS & PRECAUTIONS

Progressive multifocal leukoencephalopathy (PML): John Cunningham virus (JCV) reactivation resulting in PML and death can occur in patients treated with ADCETRIS. PML has been reported in patients who received ADCETRIS after receiving multiple prior chemotherapy regimens.

Patients should be closely monitored for new or worsening neurological, cognitive, or behavioral signs or symptoms, which may be suggestive of PML. Suggested evaluation of PML includes neurology consultation, gadolinium-enhanced magnetic resonance imaging of the brain, and cerebrospinal fluid analysis for JCV DNA by polymerase chain reaction or a brain biopsy with evidence of JCV. ADCETRIS dosing should be held for any suspected case of PML and should be permanently discontinued if a diagnosis of PML is confirmed.

Pancreatitis: Acute pancreatitis has been observed in patients treated with ADCETRIS. Fatal outcomes have been reported. Patients should be closely monitored for new or worsening abdominal pain, which may be suggestive of acute pancreatitis. Patient evaluation may include physical examination, laboratory evaluation for serum amylase and serum lipase, and abdominal imaging, such as ultrasound and other appropriate diagnostic measures. ADCETRIS should be held for any suspected case of acute pancreatitis. ADCETRIS should be discontinued if a diagnosis of acute pancreatitis is confirmed.

Pulmonary Toxicity: Cases of pulmonary toxicity, some with fatal outcomes, have been reported in patients receiving ADCETRIS. Although a causal association with ADCETRIS has not been established, the risk of pulmonary toxicity cannot be ruled out. New or worsening pulmonary symptoms should be promptly evaluated and treated appropriately.

Serious infections and opportunistic infections: Serious infections such as pneumonia, staphylococcal bacteremia, sepsis/septic shock (including fatal outcomes), and herpes zoster, and opportunistic infections such as Pneumocystis jiroveci pneumonia and oral candidiasis have been reported in patients treated with ADCETRIS. Patients should be carefully monitored during treatment for emergence of possible serious and opportunistic infections.

Infusion-related reactions (IRR): Immediate and delayed IRR, as well as anaphylaxis, have occurred with ADCETRIS. Patients should be carefully monitored during and after an infusion. If anaphylaxis occurs, administration of ADCETRIS should be immediately and permanently discontinued and appropriate medical therapy should be administered. If an IRR occurs, the infusion should be interrupted and appropriate medical management instituted. The infusion may be restarted at a slower rate after symptom resolution. Patients who have experienced a prior IRR should be premedicated for subsequent infusions. IRRs are more frequent and more severe in patients with antibodies to ADCETRIS.

Tumor lysis syndrome (TLS): TLS has been reported with ADCETRIS. Patients with rapidly proliferating tumor and high tumor burden are at risk of TLS. These patients should be monitored closely and managed according to best medical practice.

Peripheral neuropathy (PN): ADCETRIS treatment may cause PN, both sensory and motor. ADCETRIS-induced PN is typically cumulative and reversible in most cases. Patients should be monitored for symptoms of PN, such as hypoesthesia, hyperesthesia, paresthesia, discomfort, a burning sensation, neuropathic pain, or weakness. Patients experiencing new or worsening PN may require a delay and a dose reduction or discontinuation of ADCETRIS.

Hematological toxicities: Grade 3 or Grade 4 anemia, thrombocytopenia, and prolonged (equal to or greater than one week) Grade 3 or Grade 4 neutropenia can occur with ADCETRIS. Complete blood counts should be monitored prior to administration of each dose.

Febrile neutropenia: Febrile neutropenia has been reported. Patients should be monitored closely for fever and managed according to best medical practice if febrile neutropenia develops.

Stevens-Johnson syndrome (SJS): SJS and toxic epidermal necrolysis (TEN) have been reported with ADCETRIS. Fatal outcomes have been reported. If SJS or TEN occurs, treatment with ADCETRIS should be discontinued and appropriate medical therapy should be administered.

Gastrointestinal (GI) Complications: GI complications, some with fatal outcomes, including intestinal obstruction, ileus, enterocolitis, neutropenic colitis, erosion, ulcer, perforation and haemorragh, have been reported. New or worsening GI symptoms should be promptly evaluated and treated appropriately.

Hepatotoxicity: Elevations in alanine aminotransferase (ALT) and aspartate aminotransferase (AST) have been reported. Serious cases of hepatotoxicity, including fatal outcomes, have also occurred. Liver function should be tested prior to treatment initiation and routinely monitored in patients receiving ADCETRIS. Patients experiencing hepatotoxicity may require a delay, dose modification, or discontinuation of ADCETRIS.

Hyperglycemia: Hyperglycemia has been reported during trials in patients with an elevated body mass index (BMI) with or without a history of diabetes mellitus. However, any patient who experiences an event of hyperglycemia should have their serum glucose closely monitored. Anti-diabetic treatment should be administered as appropriate.

Renal and Hepatic Impairment: There is limited experience in patients with renal and hepatic impairment. Available data indicate that MMAE clearance might be affected by severe renal impairment, hepatic impairment, and by low serum albumin concentrations. The recommended starting dose in patients with hepatic impairment or severe renal impairment is 1.2 mg/kg administered as an intravenous infusion over 30 minutes every 3 weeks. Patients with renal or hepatic impairment should be closely monitored for adverse events.

Sodium content in excipients: This medicinal product contains a maximum of 2.1 mmol (or 47 mg) of sodium per dose. To be taken into consideration for patients on a controlled sodium diet.

INTERACTIONS

Patients who are receiving a strong CYP3A4 and P-gp inhibitor, concomitantly with ADCETRIS may have an increased risk of neutropenia and should be closely monitored. Co-administration of ADCETRIS with a CYP3A4 inducer did not alter the plasma exposure of ADCETRIS but it appeared to reduce plasma concentrations of MMAE metabolites that could be assayed. ADCETRIS is not expected to alter the exposure to drugs that are metabolized by CYP3A4 enzymes.

PREGNANCY: Women of childbearing potential should be using two methods of effective contraception during treatment with ADCETRIS and until 6 months after treatment. There are no data from the use of ADCETRIS in pregnant women, although studies in animals have shown reproductive toxicity. ADCETRIS should not be used during pregnancy unless the benefit to the mother outweighs the potential risks to the fetus. If a pregnant woman needs to be treated, she should be clearly advised on the potential risk to the fetus.

LACTATION (breast-feeding): There are no data as to whether ADCETRIS or its metabolites are excreted in human milk, therefore a risk to the newborn/infant cannot be excluded. With the potential risk, a decision should be made whether to discontinue breast-feeding or discontinue/abstain from therapy with ADCETRIS.

FERTILITY: In nonclinical studies, ADCETRIS treatment has resulted in testicular toxicity, and may alter male fertility. Men being treated with this medicine are advised not to father a child during treatment and for up to 6 months following the last dose.

ADVERSE REACTIONS

Serious adverse drug reactions were: pneumonia, acute respiratory distress syndrome, headache, neutropenia, thrombocytopenia, constipation, diarrhea, vomiting, nausea, pyrexia, peripheral motor neuropathy, peripheral sensory neuropathy, hyperglycemia, demyelinating polyneuropathy, tumor lysis syndrome, and Stevens-Johnson syndrome.

In the clinical studies of ADCETRIS, adverse reactions defined as very common (≥1/10) were: infection, upper respiratory tract infection, neutropenia, PN (sensory and motor), cough, dyspneoa, diarrhea, nausea, vomiting, constipation, abdominal pain, alopecia, pruritus, myalgia, arthralgia, fatigue, chills, pyrexia, infusion-related reactions and weight decreased. Adverse reactions defined as common (≥1/100 to <1/10) were: Sepsis/septic shock, herpes zoster, pneumonia, herpes simplex, anemia, thrombocytopenia, hyperglycemia, dizziness, demyelinating polyneuropathy, ALT/AST increased, rash, and back pain.

ADCETRIS (brentuximab vedotin) U.S. Important Safety Information

BOXED WARNING

Progressive multifocal leukoencephalopathy (PML): JC virus infection resulting in PML and death can occur in patients receiving ADCETRIS.

Contraindication

ADCETRIS is contraindicated with concomitant bleomycin due to pulmonary toxicity (e.g., interstitial infiltration and/or inflammation).

Warnings and Precautions

    Peripheral neuropathy (PN): ADCETRIS treatment causes a PN that is predominantly sensory. Cases of motor PN have also been reported. ADCETRIS-induced PN is cumulative. Monitor patients for symptoms of neuropathy, such as hypoesthesia, hyperesthesia, paresthesia, discomfort, a burning sensation, neuropathic pain or weakness and institute dose modifications accordingly.
    Anaphylaxis and infusion reactions: Infusion-related reactions, including anaphylaxis, have occurred with ADCETRIS. Monitor patients during infusion. If an infusion-related reaction occurs, interrupt the infusion and institute appropriate medical management. If anaphylaxis occurs, immediately and permanently discontinue the infusion and administer appropriate medical therapy. Patients who experienced a prior infusion-related reaction should be premedicated for subsequent infusions. Premedication may include acetaminophen, an antihistamine, and a corticosteroid.
    Hematologic toxicities: Prolonged (≥1 week) severe neutropenia and Grade 3 or 4 thrombocytopenia or anemia can occur with ADCETRIS. Febrile neutropenia has been reported with ADCETRIS. Monitor complete blood counts prior to each dose of ADCETRIS and consider more frequent monitoring for patients with Grade 3 or 4 neutropenia. Monitor patients for fever. If Grade 3 or 4 neutropenia develops, consider dose delays, reductions, discontinuation, or G-CSF prophylaxis with subsequent doses.
    Serious infections and opportunistic infections: Infections such as pneumonia, bacteremia, and sepsis or septic shock (including fatal outcomes) have been reported in patients treated with ADCETRIS. Closely monitor patients during treatment for the emergence of possible bacterial, fungal or viral infections.
    Tumor lysis syndrome: Closely monitor patients with rapidly proliferating tumor and high tumor burden.
    Increased toxicity in the presence of severe renal impairment: The frequency of ≥Grade 3 adverse reactions and deaths was greater in patients with severe renal impairment compared to patients with normal renal function. Avoid the use of ADCETRIS in patients with severe renal impairment.
    Increased toxicity in the presence of moderate or severe hepatic impairment: The frequency of ≥Grade 3 adverse reactions and deaths was greater in patients with moderate or severe hepatic impairment compared to patients with normal hepatic function. Avoid the use of ADCETRIS in patients with moderate or severe hepatic impairment.
    Hepatotoxicity: Serious cases of hepatotoxicity, including fatal outcomes, have occurred with ADCETRIS. Cases were consistent with hepatocellular injury, including elevations of transaminases and/or bilirubin, and occurred after the first dose of ADCETRIS or rechallenge. Preexisting liver disease, elevated baseline liver enzymes, and concomitant medications may also increase the risk.
    Monitor liver enzymes and bilirubin. Patients experiencing new, worsening, or recurrent hepatotoxicity may require a delay, change in dose, or discontinuation of ADCETRIS.
    Progressive multifocal leukoencephalopathy (PML): JC virus infection resulting in PML and death has been reported in ADCETRIS-treated patients. First onset of symptoms occurred at various times from initiation of ADCETRIS therapy, with some cases occurring within 3 months of initial exposure. In addition to ADCETRIS therapy, other possible contributory factors include prior therapies and underlying disease that may cause immunosuppression. Consider the diagnosis of PML in any patient presenting with new-onset signs and symptoms of central nervous system abnormalities. Hold ADCETRIS if PML is suspected and discontinue ADCETRIS if PML is confirmed.
    Pulmonary toxicity
    Events of noninfectious pulmonary toxicity including pneumonitis, interstitial lung disease, and acute respiratory distress syndrome, some with fatal outcomes, have been reported. Monitor patients for signs and symptoms of pulmonary toxicity, including cough and dyspnea. In the event of new or worsening pulmonary symptoms, hold ADCETRIS dosing during evaluation and until symptomatic improvement.

    Serious dermatologic reactions: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), including fatal outcomes, have been reported with ADCETRIS. If SJS or TEN occurs, discontinue ADCETRIS and administer appropriate medical therapy.
    Gastrointestinal (GI) complications: Fatal and serious GI complications, including perforation, hemorrhage, erosion, ulcer, intestinal obstruction, enterocolitis, neutropenic colitis, and ileus have been reported in ADCETRIS-treated patients. Lymphoma with preexisting GI involvement may increase the risk of perforation. In the event of new or worsening GI symptoms, perform a prompt diagnostic evaluation and treat appropriately.
    Embryo-fetal toxicity: Based on the mechanism of action and findings in animals, ADCETRIS can cause fetal harm when administered to a pregnant woman. Females of reproductive potential should avoid pregnancy during ADCETRIS treatment and for at least 6 months after the final dose of ADCETRIS.

Adverse Reactions

In two uncontrolled single-arm trials of ADCETRIS as monotherapy in 160 patients with relapsed classical HL and sALCL, the most common adverse reactions (≥20%), regardless of causality, were: neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough and vomiting.

In a placebo-controlled trial of ADCETRIS in 329 patients with classical HL at high risk of relapse or progression post-auto-HSCT, the most common adverse reactions (≥20%) in the ADCETRIS-treatment arm (167 patients), regardless of causality, were: neutropenia, peripheral sensory neuropathy, thrombocytopenia, anemia, upper respiratory tract infection, fatigue, peripheral motor neuropathy, nausea, cough, and diarrhea.

Drug Interactions

Concomitant use of strong CYP3A4 inhibitors or inducers, or P-gp inhibitors, has the potential to affect the exposure to monomethyl auristatin E (MMAE).

Use in Specific Populations

MMAE exposure and adverse reactions are increased in patients with moderate or severe hepatic impairment or severe renal impairment. Avoid use.

Advise females of reproductive potential to avoid pregnancy during ADCETRIS treatment and for at least 6 months after the final dose of ADCETRIS.

Advise males with female sexual partners of reproductive potential to use effective contraception during ADCETRIS treatment and for at least 6 months after the final dose of ADCETRIS.

Advise patients to report pregnancy immediately and avoid breastfeeding while receiving ADCETRIS.

For additional Important Safety Information, including Boxed WARNING, please see the full Prescribing Information for ADCETRIS at www.seattlegenetics.com or www.ADCETRIS.com.

About Takeda

Takeda Pharmaceutical Company Limited is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and central nervous system therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology and gastroenterology, as well as our presence in Emerging Markets, fuel the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries. For more information, visit http://www.takeda.com/news.

Additional information about Takeda is available through its corporate website, www.takeda.com, and additional information about Takeda Oncology, the brand for the global oncology business unit of Takeda Pharmaceutical Company Limited, is available through its website, www.takedaoncology.com.

About Seattle Genetics

Seattle Genetics is an innovative biotechnology company that develops and commercializes novel antibody-based therapies for the treatment of cancer. The company’s industry-leading antibody-drug conjugate (ADC) technology harnesses the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells. ADCETRIS® (brentuximab vedotin), the company’s lead product, in collaboration with Takeda Pharmaceutical Company Limited, is the first in a new class of ADCs commercially available globally in 67 countries for relapsed classical Hodgkin lymphoma and relapsed systemic anaplastic large cell lymphoma (sALCL). Seattle Genetics is also advancing enfortumab vedotin, an ADC for metastatic urothelial cancer, in a planned pivotal trial in collaboration with Astellas. Headquartered in Bothell, Washington, Seattle Genetics has a robust pipeline of innovative therapies for blood-related cancers and solid tumors designed to address significant unmet medical needs and improve treatment outcomes for patients. The company has collaborations for its proprietary ADC technology with a number of companies including AbbVie, Astellas, Bayer, Celldex, Genentech, GlaxoSmithKline and Pfizer. More information can be found at www.seattlegenetics.com

Forward Looking Statements for Seattle Genetics

Certain of the statements made in this press release are forward looking, such as those, among others, relating to the therapeutic potential of ADCETRIS (brentuximab vedotin) as the foundation of care for CD30-expressing lymphomas, anticipated publication of data from ECHELON-1 and plans for submission for supplemental regulatory approval to and obtaining regulatory approval from the FDA and other regulatory authorities. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include safety and/or efficacy results of the ECHELON-1 trial in Hodgkin lymphoma that will not be sufficient for publication or to gain marketing approval in the United States or any other country, that we will be required to amend our submission for marketing approval or that such submission will be refused or delayed. In addition, our regulatory plans may change as a result of consultation with the FDA or other regulatory authorities. More information about the risks and uncertainties faced by Seattle Genetics is contained under the caption “Risk Factors” included in the company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2017 filed with the Securities and Exchange Commission. Seattle Genetics disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contacts

Takeda
Japanese Media:
Tsuyoshi Tada, +81 (0) 3-3278-2417
tsuyoshi.tada@takeda.com
or
Media outside Japan:
Sara Noonan, 617-755-3683
sara.noonan@takeda.com
or
Seattle Genetics
Investors:
Peggy Pinkston, 425-527-4160
ppinkston@seagen.com
or
Media:
Tricia Larson, 425-527-4180
tlarson@seagen.com

Permalink : http://www.me-newswire.net/news/4147/en